NCT06883838
Project CASCADE: Community and Academic Synergy for Cancer Survivorship Care Delivery Enhancement
Enrolling by Invitation
NAAges 18+InterventionalHealth servicesThe University of Texas Health Science Center, HoustonInvestigator-initiated
~5,584 participants
Updated 2026-07-24 on ClinicalTrials.gov
What's tested:Survivorship care delivery intervention
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Proportion of eligible cancer survivors screened for second primary cancers
Measured over every 6 months from baseline to end of study (about 36 months from baseline)
Conditions
Where it's being run
1 sites across 1 statesTexas1
Study leadership
- Bijal Balasubramanian, MBBS, PhD · PRINCIPAL_INVESTIGATOR · The University of Texas Health Science Center, Houston
- Simon Craddock Lee, PhD · PRINCIPAL_INVESTIGATOR · University of Kansas Medical Center
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
at least one visit to the Community Health Centers (CHCs) in the prior year
employed clinicians (e.g. physicians, nurses, pharmacists, or other allied health professionals) and non-clinician staff of the participating CHC clinics
What this trial measures
- Proportion of eligible cancer survivors screened for second primary cancersevery 6 months from baseline to end of study (about 36 months from baseline)
Data derived from electronic health records